Description
The DoW Rare Cancers Idea Development Award is a funding opportunity that aims to promote ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation in the area of rare cancers. The award supports research that has high potential impact on rare cancers and the patient community. The proposed research must be relevant to active-duty Service Members, Veterans, military beneficiaries, and the American public. The award has a maximum period of performance of 3 years and a total cost cap of $490,000.
Some key points to consider:
• The RCRP encourages applicants to include an exploratory aim or sub-aim to support any necessary discovery-driven research.
• Preliminary data with disease-specific rationale are required, but these data do not necessarily need to originate from studies of the proposed rare cancer type(s)/subtype(s) under study.
• Research should have high potential impact on rare cancers and the patient community.
• The award mechanism is a grant, and the funding instrument will be a grant (31 USC 6304).
• The application submission is a two-step process, requiring both a pre-application and a full application.